comparemela.com

Latest Breaking News On - கார்லைல் ஆசியா கூட்டாளர்கள் - Page 10 : comparemela.com

SBI Cards share price: SBI Cards shares tank as Carlyle arm looks to offload 4% stake

SBI Cards share price: SBI Cards shares tank as Carlyle arm looks to offload 4% stake
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Stocks in Focus on March 17: Laxmi Organic Industries IPO, Craftsman Automation IPO, Nazara Technologies IPO, ITC to Tata Communication; here are the 5 Newsmakers of the Day

Stocks in Focus on March 17: Equity Benchmarks on Tuesday, March 16, 2021, ended almost flat even as the cues from other Asian stocks was positive. The BSE Sensex at Bombay Stock Exchange slipped marginally by 31 points, or 0.06 per cent, to close at 50,364 while the NSE Nifty at National Stock Exchange fell marginally by 19 points, or 0.13 per cent, to settle at 14,910. But certain stocks came in the news after the market was closed. These stocks can impact the indices when it reopens on Wednesday, March 17, 2021. List of such five stocks: Anupam Rasayan IPO + Laxmi Organic Industries IPO + Craftsman Automation IPO + Kalyan Jewellers IPO + Nazara Technologies + Suryoday Small Finance Bank:

Carlyle to sell 4% stake in SBI Cards for $514 million

Animal Health Awards: A year of diagnostics, vaccines and a triple combo blockbuster

S Hadar and  S Virchow (serogroup C). The onset of immunity is as early as four weeks after second vaccination and the duration of immunity is up to 90 weeks post-second vaccination. The firm stated: Because of the addition of a serogroup C to the existing Nobilis Salenvac ETC vaccine, MSD Animal Health can offer the broadest protection than any other competitor product, which only has the combination of  S Enteritidis and  S Typhimurium. The company has recently published results from laboratory efficacy studies that provide the basis of the  Salmonella serovar cross-protection, as well as the safety and efficacy of the vaccine under field conditions. The conclusions of both studies showed the vaccine provides significant protection against all three serogroups (B, C and D) by reducing shedding and organ invasion and this protection lasts up to 90 weeks post-second vaccination .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.